Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$28.86 -0.79 (-2.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Other Non-Current Assets (2013 - 2026)

Updated

Lakefront Biotherapeutics' Other Non-Current Assets came in at $3.46 million for the quarter ended Mar 31, 2026, up 21.5% from $2.85 million a year earlier and up 0.4% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Other Non-Current Assets (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Other Non-Current Assets was $3.34 million, down 64.5% from the prior year.

  • Other Non-Current Assets has declined in each of the last three years, with a five-year compound annual growth rate of -80.8% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Other Non-Current Assets was $9.43 million in the year ended Dec 31, 2024 (-45.5%), $17.29 million in the year ended Dec 31, 2023 (-99.7%), $6.09 billion in the year ended Dec 31, 2022 (+108.1%) and $2.93 billion in the year ended Dec 31, 2021 (-77.4%).
  • The figure for the quarter ended Mar 31, 2026 represents the highest quarterly Other Non-Current Assets since the quarter ended Dec 31, 2024.
  • Year-over-year, Other Non-Current Assets increased in 1 of the last six quarters, with an average decline of 48.8%.
  • The fastest year-over-year change in Other Non-Current Assets over five years came in the quarter ended Dec 31, 2022 (growth of 108.4%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 99.7%).
  • Business Quant data shows LKFT's Other Non-Current Assets at $3.44 million (quarter ended Dec 31, 2025), $2.91 million (quarter ended Sep 30, 2025) and $2.86 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.46 Mn
Dec 31, 2025 3.44 Mn
Sep 30, 2025 2.91 Mn
Jun 30, 2025 2.86 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 9.31 Mn
Sep 30, 2024 12.34 Mn
Mar 31, 2024 71.17 Mn
Dec 31, 2023 17.29 Mn
Sep 30, 2023 18.41 Mn
Mar 31, 2023 6.12 Mn
Dec 31, 2022 5.89 Bn
Mar 31, 2022 8.85 Mn
Dec 31, 2021 2.83 Bn
Jun 30, 2021 5.33 Mn
Dec 31, 2020 13.52 Bn
Jun 30, 2020 10.49 Mn
Mar 31, 2020 15.39 Mn
Dec 31, 2019 15.60 Bn
Sep 30, 2019 6.67 Mn
API Access

Lakefront Biotherapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LKFT&period=max&api_key=YOUR_API_KEY